Capability of auxetic femoral stems to reduce stress shielding after total hip arthroplasty.

阅读:5
作者:Liu Bolun, Wang Huizhi, Zhang Min, Li Junwei, Zhang Ningze, Luan Yichao, Fang Chaohua, Cheng Cheng-Kung
BACKGROUND: Stress shielding ​(SS) is considered the main mechanical cause of femoral stem loosening after total hip arthroplasty (THA). This study introduces an auxetic lattice femoral stem structure with negative Poisson's ratio that can expand laterally, with the intent of transferring more load to surrounding bone and thereby reducing SS. This study aims to evaluate how the geometry profile of different femoral stems with auxetic structures affects the level of SS. Different re-entrant angles for the auxetic unit cells were also evaluated. METHODS: This study assessed three commercial femoral stem designs (Mayo, CLS and Fitmore) and three re-entrant angles for the auxetic structures (60°, 70° and 80°). Nine auxetic femoral stems (three M-type, three C-type and three F-type) and three solid femoral stems (control group) were designed. All femoral stems were implanted into a finite element model of the human femur to compare levels of SS between the auxetic stems and their traditional solid counterparts. RESULTS: The results showed that incorporating an auxetic structure into the stem design caused less SS of the surrounding bone than the control models. The M-type stems had the lowest level of SS, followed by the C-type and F-type stems. A re-entrant angle of 70° for the M-type stem, 80° for the C-type stem and 60° for the F-type stem were the designs most capable of reducing SS. CONCLUSIONS: This study found that femoral stems with an auxetic lattice structure caused less SS after THA than comparable solid femoral stems. A femoral stem based on the M-type geometry profile is recommended when designing auxetic femoral stems to minimize SS of surrounding bone. THE TRANSLATIONAL POTENTIAL OF THIS ARTICLE: The novel solution provided in this study may serve to increase the survival rate of femoral stems by reducing SS after THA.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。